openPR Logo
Press release

Human Microbiome Sequencing Technology Market to Witness Strong Growth by 2028 | Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S

07-14-2022 01:35 PM CET | Health & Medicine

Press release from: ReportsnReports

Human Microbiome Sequencing Technology Market research report contains a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. Furthermore, the report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. It also examines market performance and the market position during the forecast period.

Click Here For Free Sample + Related Graphs of the Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5954741

Human Microbiome Sequencing Technology Market research report presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing crucial parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

The key players covered in this Human Microbiome Sequencing Technology Market report:

- Baseclear B.V.
- Beijing Genomics Institute (BGI) Genomics Co., Ltd
- Charles River Laboratories International Inc.
- Clinical Microbiomics A/S
- Eurofins Scientific SE
- GENEWIZ, Inc.
- Illumina, Inc.
- Novogene Corporation
- OraSure Technologies, Inc.
- Oxford Nanopore Technologies, Inc.
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Second Genome, Inc.
- Thermo Fisher Scientific Inc.
- Viome, Inc.
- CosmosID
- Leucine Rich Bio Pvt. Ltd.
- Microba
- Microbiome Insights Inc.
- Molzym GmbH & Co. KG

As the global economy mends, the 2021 growth of Human Microbiome Sequencing Technology will have significant change from previous year. According to our latest study, the global Human Microbiome Sequencing Technology market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Microbiome Sequencing Technology market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Microbiome Sequencing Technology market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Microbiome Sequencing Technology market, reaching US$ million by the year 2028. As for the Europe Human Microbiome Sequencing Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Microbiome Sequencing Technology players cover Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., and Clinical Microbiomics A/S, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Sequencing Technology market by product type, application, key players and key regions and countries.

Segmentation by type:

- Traditional Sequencing Technologies
- Next-Generation Sequencing
- Third Generation Sequencing

Segmentation by application:

- Research and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Hospital and Clinic
- Others

This report also splits the market by region:

- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries

Purchase This Report (FLAT 30% Discount): https://www.reportsnreports.com/purchase.aspx?name=5954741

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Sequencing Technology Market Size 2017-2028
2.1.2 Human Microbiome Sequencing Technology Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Microbiome Sequencing Technology Segment by Type
2.2.1 Traditional Sequencing Technologies
2.2.2 Next-Generation Sequencing
2.2.3 Third Generation Sequencing
2.3 Human Microbiome Sequencing Technology Market Size by Type
2.3.1 Human Microbiome Sequencing Technology Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Microbiome Sequencing Technology Market Size Market Share by Type (2017-2022)
2.4 Human Microbiome Sequencing Technology Segment by Application
2.4.1 Research and Academic Institutions
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Hospital and Clinic
2.4.4 Others
2.5 Human Microbiome Sequencing Technology Market Size by Application
2.5.1 Human Microbiome Sequencing Technology Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Microbiome Sequencing Technology Market Size Market Share by Application (2017-2022)
3 Human Microbiome Sequencing Technology Market Size by Player
3.1 Human Microbiome Sequencing Technology Market Size Market Share by Players
3.1.1 Global Human Microbiome Sequencing Technology Revenue by Players (2020-2022)
3.1.2 Global Human Microbiome Sequencing Technology Revenue Market Share by Players (2020-2022)
3.2 Global Human Microbiome Sequencing Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Microbiome Sequencing Technology by Regions
4.1 Human Microbiome Sequencing Technology Market Size by Regions (2017-2022)
4.2 Americas Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.3 APAC Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.4 Europe Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Microbiome Sequencing Technology Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
5.2 Americas Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
5.3 Americas Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Microbiome Sequencing Technology Market Size by Region (2017-2022)
6.2 APAC Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
6.3 APAC Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Microbiome Sequencing Technology by Country (2017-2022)
7.2 Europe Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
7.3 Europe Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Microbiome Sequencing Technology by Region (2017-2022)
8.2 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Microbiome Sequencing Technology Market Forecast

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Microbiome Sequencing Technology Market to Witness Strong Growth by 2028 | Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S here

News-ID: 2680255 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the